JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB108353

Anti-Aurora A antibody [EPR5026] - Centrosome Marker

  • 20ul selling size
  • RabMAb
  • Recombinant
  • Lab Essentials
  • What is this?

0

(1 Review)

|

(10 Publications )

Rabbit Recombinant Monoclonal Aurora A antibody. Centrosome marker. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Mouse, Human samples. Cited in 10 publications.

View Alternative Names

AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6, AURKA, Aurora kinase A, Aurora 2, Aurora/IPL1-related kinase 1, Breast tumor-amplified kinase, Ipl1- and aurora-related kinase 1, Serine/threonine-protein kinase 15, Serine/threonine-protein kinase 6, Serine/threonine-protein kinase Ayk1, Serine/threonine-protein kinase aurora-A, ARK-1, Aurora-related kinase 1

7 Images
Immunocytochemistry/ Immunofluorescence - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (AB108353)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (AB108353)

Immunofluorescent staining of HeLa cells using ab108353 at 1/100

Flow Cytometry (Intracellular) - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (AB108353)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (AB108353)

Overlay histogram showing HeLa cells stained with ab108353 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab108353 1/1000 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.

Immunoprecipitation - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (AB108353)
  • IP

Lab

Immunoprecipitation - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (AB108353)

Lane 1 : HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate 10μg
Lane 2 :
HepG2 cell lysate 350μg and ab109518 2μg
Lane 3 :
HepG2 cell lysate 350μg and rabbit IgG (ab172730) , 2μg

Purified ab108353 immunoprecipitating Aurora A in Neuro2a cell lysates. Primary antibody was used at a 1/60 dilution (20 μg/ml). For western blotting, ab108353 at 1/500 and VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.

Blocking and diluting buffer used : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (ab108353)

Predicted band size: 45 kDa

false

Immunoprecipitation - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (AB108353)
  • IP

Lab

Immunoprecipitation - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (AB108353)

Lane 1 : Neuro2a (Mouse neuroblastoma neuroblast) whole cell lysate, 10μg
Lane 2 :
Neuro2a cell lysate 350μg and ab109518 2μg
Lane 3 :
Neuro2a cell lysate, 350μg and rabbit IgG (ab172730) , 2μg

Purified ab108353 immunoprecipitating Aurora A in Neuro2a cell lysates. Primary antibody was used at a 1/60 dilution (20 μg/ml). For western blotting, ab108353 at 1/500 and VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.

Blocking and diluting buffer used : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (ab108353)

Predicted band size: 45 kDa

false

Western blot - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (AB108353)
  • WB

Unknown

Western blot - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (AB108353)

All lanes:

Western blot - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (ab108353) at 1/1000 dilution

Lane 1:

BXPC-3 cell lysate at 10 µg

Lane 2:

LnCaP cell lysate at 10 µg

Lane 3:

SKBR-3 cell lysate at 10 µg

Lane 4:

HepG2 cell lysate at 10 µg

Predicted band size: 45 kDa

false

Western blot - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (AB108353)
  • WB

Unknown

Western blot - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (AB108353)

All lanes:

Western blot - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (ab108353) at 1/1000 dilution

All lanes:

Neuro-2a cell lysate at 10 µg

Predicted band size: 134 kDa,45 kDa,53 kDa,86 kDa

false

OI-RD Scanning - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (AB108353)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-Aurora A antibody [EPR5026] - Centrosome Marker (AB108353)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

  • Carrier free

    Anti-Aurora A antibody [EPR5026] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR5026

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

Flow Cyt (Intra), IP, WB, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/60", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/250", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/1000 - 1/10000", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" }, "Mouse": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/60", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine, 0.1% BSA
Shipped at conditions
Conditional Ambient
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Aurora A also known as Aurora kinase A is an important serine/threonine kinase with a protein mass of approximately 46 kDa. It is commonly found in various tissues but its expression is particularly high during mitosis in dividing cells. Aurora A operates primarily at the centrosomes where it is pivotal for processes such as centrosome maturation separation and the establishment of the mitotic spindle. The kinase activity of Aurora A is important for proper chromosome alignment and segregation. Scientists often use Aurora A as a marker in studies related to cell division and cancer.
Biological function summary

Aurora A plays key roles in the regulation of the cell cycle and mitosis. It functions as part of the Aurora mouse kinase complex associating with other proteins to ensure accurate chromosomal segregation and cytokinesis. Aurora A is involved in centrosome dynamics and interacts with proteins such as 35C1 aiding its localization to the correct cellular structures. The protein’s role in the cell cycle and mitotic checkpoints makes it a subject of interest for researchers examining cancer proliferation.

Pathways

Aurora A integrates into both the mitotic spindle assembly checkpoint and DNA damage repair pathways. Within these pathways Aurora A partners with proteins like APC (Anaphase Promoting Complex) to ensure timely progression through mitosis and safeguard genomic stability. The spindle assembly pathway ensures that spindle fibers correctly attach to chromosomes a process in which Aurora A proves instrumental. Its interaction with other kinases and regulatory molecules in these pathways highlights its regulatory importance in cell proliferation.

Research identifies Aurora A's association with oncological conditions such as breast and ovarian cancers. Overexpression or amplification of Aurora A correlates with tumor progression and poor prognosis as it can lead to chromosomal instability. In these diseases Aurora A activity is linked with dysregulated pathways involving proteins like p53 and BRCA1 which normally function in DNA damage response and repair. Targeted inhibition of Aurora A represents a promising avenue in cancer therapy as it might restore normal cell cycle control and reduce cancer cell viability.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Mitotic serine/threonine kinase that contributes to the regulation of cell cycle progression (PubMed : 11039908, PubMed : 12390251, PubMed : 17125279, PubMed : 17360485, PubMed : 18615013, PubMed : 26246606). Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis (PubMed : 14523000, PubMed : 26246606). Required for normal spindle positioning during mitosis and for the localization of NUMA1 and DCTN1 to the cell cortex during metaphase (PubMed : 27335426). Required for initial activation of CDK1 at centrosomes (PubMed : 13678582, PubMed : 15128871). Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2 (PubMed : 11551964, PubMed : 14702041, PubMed : 15128871, PubMed : 15147269, PubMed : 15987997, PubMed : 17604723, PubMed : 18056443, PubMed : 18615013). Phosphorylates MCRS1 which is required for MCRS1-mediated kinetochore fiber assembly and mitotic progression (PubMed : 27192185). Regulates KIF2A tubulin depolymerase activity (PubMed : 19351716). Important for microtubule formation and/or stabilization (PubMed : 18056443). Required for normal axon formation (PubMed : 19812038). Plays a role in microtubule remodeling during neurite extension (PubMed : 19668197). Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and destabilizing p53/TP53 (PubMed : 14702041). Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity (PubMed : 11551964). Inhibits cilia outgrowth (By similarity). Required for cilia disassembly via phosphorylation of HDAC6 and subsequent deacetylation of alpha-tubulin (PubMed : 17604723, PubMed : 20643351). Regulates protein levels of the anti-apoptosis protein BIRC5 by suppressing the expression of the SCF(FBXL7) E3 ubiquitin-protein ligase substrate adapter FBXL7 through the phosphorylation of the transcription factor FOXP1 (PubMed : 28218735).
See full target information AURKA

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Journal of nanobiotechnology 22:803 PubMed39734237

2024

Targeting AURKA with multifunctional nanoparticles in CRPC therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Bin Deng,Binghu Ke,Qixing Tian,Yukui Gao,Qiliang Zhai,Wenqiang Zhang

Journal of nanobiotechnology 22:744 PubMed39614277

2024

Enhancing radiotherapy in triple-negative breast cancer with hesperetin-induced ferroptosis via AURKA targeting nanocomposites.

Applications

Unspecified application

Species

Unspecified reactive species

Yang Guo,Huan Wang,Xinlei Wang,Keyan Chen,Liang Feng

Journal of translational medicine 22:871 PubMed39334121

2024

Vascular restenosis following paclitaxel-coated balloon therapy is attributable to NLRP3 activation and LIN9 upregulation.

Applications

Unspecified application

Species

Unspecified reactive species

Qinghui Kan,Zhanli Peng,Kangjie Wang,Tang Deng,Zhihao Zhou,Ridong Wu,Chen Yao,Rui Wang

Cancer gene therapy 30:1007-1017 PubMed36973424

2023

E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA.

Applications

Unspecified application

Species

Unspecified reactive species

Hao-Ming Shen,Di Zhang,Ping Xiao,Bin Qu,Yi-Fan Sun

Frontiers in endocrinology 13:1106175 PubMed36601001

2022

and are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine.

Applications

Unspecified application

Species

Unspecified reactive species

Xi Chen,Junjie Ma,Xin'an Wang,Tong Zi,Duocheng Qian,Chao Li,Chengdang Xu

Journal of clinical laboratory analysis 36:e24758 PubMed36377304

2022

The role of AURKA/miR-199b-3p in hepatocellular carcinoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Guogang Li,Yang Tian,Zhenzhen Gao

Pathology international 73:109-119 PubMed36285444

2022

Salt-like transcription factor 4 promotes laryngeal cancer progression through transcriptional activation of ubiquitin-specific protease 21 to stabilize Yin Yang 1.

Applications

Unspecified application

Species

Unspecified reactive species

Qing-Dong Wang,Li-Li Liu,Di Li,Li Gao,Mei-Jia Zhang

Reproductive biology and endocrinology : RB&E 19:162 PubMed34715887

2021

Effects of Aurora kinase A on mouse decidualization via Stat3-plk1-cdk1 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Peng-Chao Wang,Si-Ting Chen,Zeng-Ming Yang

Scientific reports 11:14253 PubMed34244565

2021

Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.

Applications

Unspecified application

Species

Unspecified reactive species

Helin Wang,Kangze Feng,Qingtao Wang,Haiteng Deng

Proceedings of the National Academy of Sciences of 114:E990-E998 PubMed28115701

2017

Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Karin Hoppe-Seyler,Felicitas Bossler,Claudia Lohrey,Julia Bulkescher,Frank Rösl,Lars Jansen,Arnulf Mayer,Peter Vaupel,Matthias Dürst,Felix Hoppe-Seyler
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com